Loading…

Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity

Carbocyclic analogs of several naturally occurring and biologically active purine nucleosides have been synthesized (1–4). In these analogs a methylene group occupies the position of the ring oxygen atom of the ribo- or deoxyribofuranosides. Because of the presence of a stable carbon-nitrogen bond a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical sciences 1973-05, Vol.62 (5), p.858-859
Main Authors: Fulmer Shealy, Y., Clayton, Joe D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3
cites cdi_FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3
container_end_page 859
container_issue 5
container_start_page 858
container_title Journal of pharmaceutical sciences
container_volume 62
creator Fulmer Shealy, Y.
Clayton, Joe D.
description Carbocyclic analogs of several naturally occurring and biologically active purine nucleosides have been synthesized (1–4). In these analogs a methylene group occupies the position of the ring oxygen atom of the ribo- or deoxyribofuranosides. Because of the presence of a stable carbon-nitrogen bond at position 9 of the purine moiety, these analogs are not subject to cleavage by enzymes that remove or transfer the ribofuranosyl moiety of the nucleosides or nucleotides. Biochemical studies (5–7) have shown that the racemic analog (III) of adenosine can serve either as a substrate for or as an inhibitor of some of the enzymes involved in purine nucleotide metabolism, one of the more interesting findings being the inhibition of guanylic acid kinase by the phosphate (7). The antibiotic aristeromycin (8). the optically active form (9, 10) of the adenosine analog, inhibits certain plant pathogens (8, 11). Several racemic carbocyclic analogs of purine nucleosides are cytotoxic to neoplastic cells growing in culture (4). In this communication, antileukemic activity in vivo by a carbocyclic analog, the 8-azaadenosine analog (II), is reported.
doi_str_mv 10.1002/jps.2600620547
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_81917330</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354915410354</els_id><sourcerecordid>81917330</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3</originalsourceid><addsrcrecordid>eNqFkMFO3DAURa2qFR2gW3aVsuou02cntpMlmrYDCFEErSp1YznOMzVk4sFOgPl7PMqIqouKlRfv3GvdQ8gRhTkFYJ9v13HOBIBgwEv5hswoZ5ALoPItmSWA5QUv6_dkP8ZbSBhwvkf2SglcUpiR5UKHxpuN6ZzJjnvd-ZvM2-xyDK7H7Mo1vh9Nhz66FmP26IY_iRpch-MdrrYRM7gHN2wOyTuru4gfdu8B-fnt64_FSX7-fXm6OD7PTcmkzAvkbVlaDjVUwjItZKNtK6BomkobYNpUhjIrZCHKWhaWYmMqxnTNDGtqa4sD8mnqXQd_P2Ic1MpFg12ne_RjVBWtqSwKSOB8Ak3wMQa0ah3cSoeNoqC25lQyp_6aS4GPu-axWWH7gu9UpXs93R_T-s0rbers8vqf7nzKujjg00tWhzuVpkqufl0sFYeLL9dXv4Xa_lVNPCaVDw6DisZhb7B1Ac2gWu_-N-MZHaCcEg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>81917330</pqid></control><display><type>article</type><title>Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity</title><source>Wiley-Blackwell Journals</source><creator>Fulmer Shealy, Y. ; Clayton, Joe D.</creator><creatorcontrib>Fulmer Shealy, Y. ; Clayton, Joe D.</creatorcontrib><description>Carbocyclic analogs of several naturally occurring and biologically active purine nucleosides have been synthesized (1–4). In these analogs a methylene group occupies the position of the ring oxygen atom of the ribo- or deoxyribofuranosides. Because of the presence of a stable carbon-nitrogen bond at position 9 of the purine moiety, these analogs are not subject to cleavage by enzymes that remove or transfer the ribofuranosyl moiety of the nucleosides or nucleotides. Biochemical studies (5–7) have shown that the racemic analog (III) of adenosine can serve either as a substrate for or as an inhibitor of some of the enzymes involved in purine nucleotide metabolism, one of the more interesting findings being the inhibition of guanylic acid kinase by the phosphate (7). The antibiotic aristeromycin (8). the optically active form (9, 10) of the adenosine analog, inhibits certain plant pathogens (8, 11). Several racemic carbocyclic analogs of purine nucleosides are cytotoxic to neoplastic cells growing in culture (4). In this communication, antileukemic activity in vivo by a carbocyclic analog, the 8-azaadenosine analog (II), is reported.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.2600620547</identifier><identifier>PMID: 4705710</identifier><language>eng</language><publisher>Washington: Elsevier Inc</publisher><subject>5-d]pyrimidine (carbocyclic analog of purine nucleoside) ; 5-d]pyrimidines-synthesis of 8-azaadenosine analog of purine nucleoside ; antileukemic activity ; Antileukemic activity-synthesis of a v-triazolo ; Antileukemic activity—synthesis of a v-triazolo[4,5-d]pyrimidine (carbocyclic analog of purine nucleoside) ; Aza Compounds - therapeutic use ; Carbocyclic analogs of purine nucleosides (8- azaadenosine analog)—synthesis, antileukemic activity ; Carbocyclic analogs of purine nucleosides (8-azaadenosine analog)-synthesis ; Carcinoma, Squamous Cell - drug therapy ; Cells, Cultured ; Humans ; Leukemia - drug therapy ; Neoplasms, Experimental - drug therapy ; Purine ribonucleosides-synthesis of carbocyclic analog with antileukemic activity ; Purines - chemical synthesis ; Purines - therapeutic use ; Ribonucleosides - chemical synthesis ; Ribonucleosides - therapeutic use ; Triazoles - therapeutic use ; v-Triazolo ; v-Triazolo[4,5-d]pyrimidines—synthesis of 8-azaadenosine analog of purine nucleoside, antileukemic activity</subject><ispartof>Journal of pharmaceutical sciences, 1973-05, Vol.62 (5), p.858-859</ispartof><rights>1973 Wiley-Liss, Inc., A Wiley Company</rights><rights>Copyright © 1973 Wiley‐Liss, Inc., A Wiley Company</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3</citedby><cites>FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.2600620547$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.2600620547$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/4705710$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fulmer Shealy, Y.</creatorcontrib><creatorcontrib>Clayton, Joe D.</creatorcontrib><title>Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>Carbocyclic analogs of several naturally occurring and biologically active purine nucleosides have been synthesized (1–4). In these analogs a methylene group occupies the position of the ring oxygen atom of the ribo- or deoxyribofuranosides. Because of the presence of a stable carbon-nitrogen bond at position 9 of the purine moiety, these analogs are not subject to cleavage by enzymes that remove or transfer the ribofuranosyl moiety of the nucleosides or nucleotides. Biochemical studies (5–7) have shown that the racemic analog (III) of adenosine can serve either as a substrate for or as an inhibitor of some of the enzymes involved in purine nucleotide metabolism, one of the more interesting findings being the inhibition of guanylic acid kinase by the phosphate (7). The antibiotic aristeromycin (8). the optically active form (9, 10) of the adenosine analog, inhibits certain plant pathogens (8, 11). Several racemic carbocyclic analogs of purine nucleosides are cytotoxic to neoplastic cells growing in culture (4). In this communication, antileukemic activity in vivo by a carbocyclic analog, the 8-azaadenosine analog (II), is reported.</description><subject>5-d]pyrimidine (carbocyclic analog of purine nucleoside)</subject><subject>5-d]pyrimidines-synthesis of 8-azaadenosine analog of purine nucleoside</subject><subject>antileukemic activity</subject><subject>Antileukemic activity-synthesis of a v-triazolo</subject><subject>Antileukemic activity—synthesis of a v-triazolo[4,5-d]pyrimidine (carbocyclic analog of purine nucleoside)</subject><subject>Aza Compounds - therapeutic use</subject><subject>Carbocyclic analogs of purine nucleosides (8- azaadenosine analog)—synthesis, antileukemic activity</subject><subject>Carbocyclic analogs of purine nucleosides (8-azaadenosine analog)-synthesis</subject><subject>Carcinoma, Squamous Cell - drug therapy</subject><subject>Cells, Cultured</subject><subject>Humans</subject><subject>Leukemia - drug therapy</subject><subject>Neoplasms, Experimental - drug therapy</subject><subject>Purine ribonucleosides-synthesis of carbocyclic analog with antileukemic activity</subject><subject>Purines - chemical synthesis</subject><subject>Purines - therapeutic use</subject><subject>Ribonucleosides - chemical synthesis</subject><subject>Ribonucleosides - therapeutic use</subject><subject>Triazoles - therapeutic use</subject><subject>v-Triazolo</subject><subject>v-Triazolo[4,5-d]pyrimidines—synthesis of 8-azaadenosine analog of purine nucleoside, antileukemic activity</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1973</creationdate><recordtype>article</recordtype><recordid>eNqFkMFO3DAURa2qFR2gW3aVsuou02cntpMlmrYDCFEErSp1YznOMzVk4sFOgPl7PMqIqouKlRfv3GvdQ8gRhTkFYJ9v13HOBIBgwEv5hswoZ5ALoPItmSWA5QUv6_dkP8ZbSBhwvkf2SglcUpiR5UKHxpuN6ZzJjnvd-ZvM2-xyDK7H7Mo1vh9Nhz66FmP26IY_iRpch-MdrrYRM7gHN2wOyTuru4gfdu8B-fnt64_FSX7-fXm6OD7PTcmkzAvkbVlaDjVUwjItZKNtK6BomkobYNpUhjIrZCHKWhaWYmMqxnTNDGtqa4sD8mnqXQd_P2Ic1MpFg12ne_RjVBWtqSwKSOB8Ak3wMQa0ah3cSoeNoqC25lQyp_6aS4GPu-axWWH7gu9UpXs93R_T-s0rbers8vqf7nzKujjg00tWhzuVpkqufl0sFYeLL9dXv4Xa_lVNPCaVDw6DisZhb7B1Ac2gWu_-N-MZHaCcEg</recordid><startdate>197305</startdate><enddate>197305</enddate><creator>Fulmer Shealy, Y.</creator><creator>Clayton, Joe D.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>197305</creationdate><title>Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity</title><author>Fulmer Shealy, Y. ; Clayton, Joe D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1973</creationdate><topic>5-d]pyrimidine (carbocyclic analog of purine nucleoside)</topic><topic>5-d]pyrimidines-synthesis of 8-azaadenosine analog of purine nucleoside</topic><topic>antileukemic activity</topic><topic>Antileukemic activity-synthesis of a v-triazolo</topic><topic>Antileukemic activity—synthesis of a v-triazolo[4,5-d]pyrimidine (carbocyclic analog of purine nucleoside)</topic><topic>Aza Compounds - therapeutic use</topic><topic>Carbocyclic analogs of purine nucleosides (8- azaadenosine analog)—synthesis, antileukemic activity</topic><topic>Carbocyclic analogs of purine nucleosides (8-azaadenosine analog)-synthesis</topic><topic>Carcinoma, Squamous Cell - drug therapy</topic><topic>Cells, Cultured</topic><topic>Humans</topic><topic>Leukemia - drug therapy</topic><topic>Neoplasms, Experimental - drug therapy</topic><topic>Purine ribonucleosides-synthesis of carbocyclic analog with antileukemic activity</topic><topic>Purines - chemical synthesis</topic><topic>Purines - therapeutic use</topic><topic>Ribonucleosides - chemical synthesis</topic><topic>Ribonucleosides - therapeutic use</topic><topic>Triazoles - therapeutic use</topic><topic>v-Triazolo</topic><topic>v-Triazolo[4,5-d]pyrimidines—synthesis of 8-azaadenosine analog of purine nucleoside, antileukemic activity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fulmer Shealy, Y.</creatorcontrib><creatorcontrib>Clayton, Joe D.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fulmer Shealy, Y.</au><au>Clayton, Joe D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>1973-05</date><risdate>1973</risdate><volume>62</volume><issue>5</issue><spage>858</spage><epage>859</epage><pages>858-859</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><abstract>Carbocyclic analogs of several naturally occurring and biologically active purine nucleosides have been synthesized (1–4). In these analogs a methylene group occupies the position of the ring oxygen atom of the ribo- or deoxyribofuranosides. Because of the presence of a stable carbon-nitrogen bond at position 9 of the purine moiety, these analogs are not subject to cleavage by enzymes that remove or transfer the ribofuranosyl moiety of the nucleosides or nucleotides. Biochemical studies (5–7) have shown that the racemic analog (III) of adenosine can serve either as a substrate for or as an inhibitor of some of the enzymes involved in purine nucleotide metabolism, one of the more interesting findings being the inhibition of guanylic acid kinase by the phosphate (7). The antibiotic aristeromycin (8). the optically active form (9, 10) of the adenosine analog, inhibits certain plant pathogens (8, 11). Several racemic carbocyclic analogs of purine nucleosides are cytotoxic to neoplastic cells growing in culture (4). In this communication, antileukemic activity in vivo by a carbocyclic analog, the 8-azaadenosine analog (II), is reported.</abstract><cop>Washington</cop><pub>Elsevier Inc</pub><pmid>4705710</pmid><doi>10.1002/jps.2600620547</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 1973-05, Vol.62 (5), p.858-859
issn 0022-3549
1520-6017
language eng
recordid cdi_proquest_miscellaneous_81917330
source Wiley-Blackwell Journals
subjects 5-d]pyrimidine (carbocyclic analog of purine nucleoside)
5-d]pyrimidines-synthesis of 8-azaadenosine analog of purine nucleoside
antileukemic activity
Antileukemic activity-synthesis of a v-triazolo
Antileukemic activity—synthesis of a v-triazolo[4,5-d]pyrimidine (carbocyclic analog of purine nucleoside)
Aza Compounds - therapeutic use
Carbocyclic analogs of purine nucleosides (8- azaadenosine analog)—synthesis, antileukemic activity
Carbocyclic analogs of purine nucleosides (8-azaadenosine analog)-synthesis
Carcinoma, Squamous Cell - drug therapy
Cells, Cultured
Humans
Leukemia - drug therapy
Neoplasms, Experimental - drug therapy
Purine ribonucleosides-synthesis of carbocyclic analog with antileukemic activity
Purines - chemical synthesis
Purines - therapeutic use
Ribonucleosides - chemical synthesis
Ribonucleosides - therapeutic use
Triazoles - therapeutic use
v-Triazolo
v-Triazolo[4,5-d]pyrimidines—synthesis of 8-azaadenosine analog of purine nucleoside, antileukemic activity
title Carbocyclic Analog of Purine Ribonucleosides with Antileukemic Activity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A52%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbocyclic%20Analog%20of%20Purine%20Ribonucleosides%20with%20Antileukemic%20Activity&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Fulmer%20Shealy,%20Y.&rft.date=1973-05&rft.volume=62&rft.issue=5&rft.spage=858&rft.epage=859&rft.pages=858-859&rft.issn=0022-3549&rft.eissn=1520-6017&rft_id=info:doi/10.1002/jps.2600620547&rft_dat=%3Cproquest_cross%3E81917330%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4277-3e5d44f509086f2a67bafd603bb8ac02ac8c12f67364973f1ebc822a92c2b9ff3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=81917330&rft_id=info:pmid/4705710&rfr_iscdi=true